Bone Biologics Corp (BBLGW) — 10-Q Filings

10-Q Filings (6)

• Bone Biologics Narrows Loss, Boosts Cash Amid Going Concern Doubts — Nov 14, 2025 Risk: high
  Bone Biologics Corp (BBLGW) reported no revenue for the nine months ended September 30, 2025, consistent with the prior year. The company incurred a net loss of
• Bone Biologics' Cash Boosted by Offering, But Going Concern Doubts Linger — Aug 14, 2025 Risk: high
  Bone Biologics Corp (BBLGW) reported a net loss of $1.76 million for the six months ended June 30, 2025, an increase from a net loss of $1.65 million in the sam
• Bone Biologics Files Q1 2025 10-Q — May 12, 2025 Risk: medium
  Bone Biologics Corp. filed its Q1 2025 10-Q report on May 12, 2025, for the period ending March 31, 2025. The company, based in Burlington, MA, operates in the
• Bone Biologics Files Q3 2024 10-Q — Nov 14, 2024 Risk: medium
  Bone Biologics Corp. filed its 10-Q for the period ending September 30, 2024. The company, located at 2 Burlington Woods Drive, Suite 100, Burlington, MA, repor
• Bone Biologics Files Q2 2024 10-Q — Aug 9, 2024 Risk: medium
  Bone Biologics Corp filed its 10-Q for the period ending June 30, 2024. The company, based in Burlington, MA, operates in the orthopedic, prosthetic & surgical
• Bone Biologics Corp Q1 2024 10-Q Filing — May 14, 2024 Risk:
  Bone Biologics Corp (BBLGW) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Revenue for the three months ended March 31, 2024, was $0. Net loss fo

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX